Lansoprazole Tablet, Orally Disintegrating, Delayed Release
FDA Recall NDC 0093-3009

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Lansoprazole (NDC 0093-3009). A significant event, classified as Class III, was initiated on Mar 11, 2019 by Teva Pharmaceuticals Usa, Inc.. The reported reason for this action was: "Subpotent Drug."

This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.

Reported Recall Events

March 2019 Class III Recall: Subpotent Drug.

Recall Number
Class III Terminated
Reason for Recall
Subpotent Drug.
Initiated
Mar 11, 2019
Reported
Mar 27, 2019
Quantity
7,081 bottles

Recall Profile & Regulatory Data

Event ID
82367
Classification
Class III
Enforcement Status
Terminated
Recalling Firm
Teva Pharmaceuticals USA
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the United States.
Termination Date
Nov 15, 2019
Product Description
Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402, Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93
Batch or Lot Expiration Information
Lot# : 25Q002, Exp. 11/2019
Affected Packages Involved in this Recall
0093-3008-19Product
0093-3008-93Product
0093-3009-19Product
0093-3009-93Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.